Lars Schimmöller

24PUBLICATIONS
49CO-AUTHORS
Medical infection agents (incl. prions)Medical biotechnology diagnostics (incl. biosensors)Cancer diagnosisGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Dec 11, 2025
Analysis of Operator Expertise in MRI/TRUS Fusion-Guided Prostate Biopsy.

Rouvier Al-Monajjed, Lars Schimmöller, Jale Lakes

|Jan 27, 2025
Squared diffusion-weighted imaging for improving the detection of clinically significant prostate cancer.

Birte Valentin, Lars Schimmöller, Matthias Boschheidgen

|Jan 08, 2025
Evaluation of the current status, significance, and availability of prostate MRI und MRI guided biopsy in Germany.

Tim Ullrich, Matthias Boschheidgen, Caroline Marie Schweyen

|Sep 13, 2024
MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer.

M Boschheidgen, L Schimmöller, J P Radtke

|Apr 06, 2024
Spectral Diffusion Analysis in Patients With High Risk for Prostate Cancer: A Feasibility Study.

Thomas A Thiel, Birte Valentin, Tim Ullrich

Pageof 4